Garcinia Biflavonoid 1 Improves Lipid Metabolism in HepG2 Cells via Regulating PPARα.

PPARα fatty acid oxidation garcinia biflavonoid 1 lipid metabolism

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 Mar 2022
Historique:
received: 09 02 2022
revised: 15 03 2022
accepted: 15 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 31 3 2022
Statut: epublish

Résumé

Garcinia biflavonoid 1 (GB1) is one of the active chemical components of

Identifiants

pubmed: 35335339
pii: molecules27061978
doi: 10.3390/molecules27061978
pmc: PMC8950208
pii:
doi:

Substances chimiques

Biflavonoids 0
PPAR alpha 0
Garcinia biflavonoid 1 14736-58-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Science and Technology Project of Guangdong Province
ID : 2021A0505030060
Organisme : 2021A0505030060
ID : 2019-43
Organisme : Special project of international cooperation in TCM of NATCM
ID : GZYYGJ2021

Références

Gastroenterology. 2001 Apr;120(5):1183-92
pubmed: 11266382
J Pharm Pharmacol. 2006 Jan;58(1):121-8
pubmed: 16393472
Curr Pharm Des. 2021;27(4):490-504
pubmed: 33185157
J Hepatol. 2015 Jul;63(1):164-73
pubmed: 25703085
Dig Dis Sci. 2015 Nov;60(11):3194-202
pubmed: 26017679
Cell Metab. 2007 Jun;5(6):426-37
pubmed: 17550778
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90
pubmed: 24042449
Clin Exp Pharmacol Physiol. 2005 Jan-Feb;32(1-2):40-6
pubmed: 15730433
J Hepatol. 2015 Mar;62(3):720-33
pubmed: 25450203
BMC Med. 2017 Feb 28;15(1):45
pubmed: 28241825
Cell Rep. 2019 Dec 17;29(12):4127-4143.e8
pubmed: 31851938
Basic Clin Pharmacol Toxicol. 2006 Feb;98(2):135-41
pubmed: 16445585
Front Med (Lausanne). 2021 Sep 07;8:654867
pubmed: 34557497
Dig Dis Sci. 2016 May;61(5):1234-45
pubmed: 26921078
J Pharm Pharmacol. 1990 Apr;42(4):290-2
pubmed: 1974302
Nature. 2014 Dec 4;516(7529):112-5
pubmed: 25383539
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102
J Clin Invest. 2004 Jul;114(1):94-103
pubmed: 15232616
Molecules. 2021 Oct 08;26(19):
pubmed: 34641631
Phytomedicine. 2014 Dec 15;21(14):1785-93
pubmed: 25481391
J Clin Invest. 1999 Jun;103(11):1489-98
pubmed: 10359558
Nutr Metab Cardiovasc Dis. 2009 May;19(4):291-302
pubmed: 19359149
Gut. 2016 Jul;65(7):1202-14
pubmed: 26838599
Nat Med. 2004 Apr;10(4):355-61
pubmed: 15057233
World J Gastroenterol. 2018 Jul 21;24(27):2974-2983
pubmed: 30038464
J Med Food. 2009 Jun;12(3):584-90
pubmed: 19627207
Food Chem Toxicol. 2000 Jun;38(6):535-41
pubmed: 10828505
J Diabetes Res. 2020 Jul 31;2020:3920196
pubmed: 32832560

Auteurs

Hai-Xin Chen (HX)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Fan Yang (F)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Xin-Qian He (XQ)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Ting Li (T)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Yong-Zhi Sun (YZ)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Jian-Ping Song (JP)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Xin-An Huang (XA)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Wen-Feng Guo (WF)

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH